Literature DB >> 11481307

Use of fluconazole in daily practice: still room for improvement.

S Natsch1, M H Steeghs, Y A Hekster, J F Meis, J W van der Meer, B J Kullberg.   

Abstract

One hundred courses of fluconazole treatment in a university hospital and 81 courses in a non-university teaching hospital have been analysed in a prospective audit to evaluate prescribing practices. The quality of treatments was assessed by an infectious disease specialist and a pharmacist according to standard guidelines. In the non-university hospital, prescribed dosages were lower than in the university hospital, and often below the recommended dose. Mean duration of treatment for oesophageal candidosis and disseminated infections was considerably shorter in the non-university hospital compared with the university hospital, and often judged too short. Microbiological samples were examined in 75% of the cases in both hospitals. The expert reviewers agreed with the indication to use fluconazole in 58-100% of cases in the university hospital and 42-80% in the non-university hospital, depending on the type of infection. There did not appear to be a major problem with inappropriate use of fluconazole. However, important issues for improvement could be identified, such as increasing the dosage and duration of treatment in cases of serious infections, and withholding treatment from patients with colonization rather than infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481307     DOI: 10.1093/jac/48.2.303

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Duration of antifungal treatment and development of delayed complications in patients with candidaemia.

Authors:  A M L Oude Lashof; J P Donnelly; J F G M Meis; J W M van der Meer; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

3.  Utilization of fluconazole in an intensive care unit at a university hospital in Brazil.

Authors:  Tânia Pereira Salci; Marina Gimenes; Carlos Aparecido dos Santos; Terezinha Inez Estivalet Svidzinski; Silvana Martins Caparroz-Assef
Journal:  Int J Clin Pharm       Date:  2012-11-28

4.  Hospital use of systemic antifungal drugs.

Authors:  Katja de With; Michaela Steib-Bauert; Holger Knoth; Frank Dörje; Egid Strehl; Ulrich Rothe; Ludwig Maier; Winfried V Kern
Journal:  BMC Clin Pharmacol       Date:  2005-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.